 Home > Biochemistry News > Biotechnology News > A new strategy to treat Huntington's disease

A new strategy to treat Huntington's disease

 Last Update: 2022-09-07
 Source: Internet
 Author: User

Tags

pharmaceutical research

integral proteins called

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

The study, co-authored by Jin Jiongzhu (transliteration), was published in the online edition of the Journal of Clinical Investigation Insights on August 9, 2022, with the title "A pathogenic proteolysis-resistant huntingtin isoform induced by an antisense oligonucleotide maintains huntingtin function.

Huntington's disease is a dominantly inherited neurodegenerative disorder caused by mutations in a protein called "huntingtin," which increases a protein called "polyglutamine.

Cleavage near stretched polyglutamine in mutant huntingtin is thought to be responsible for Huntington's disease

This work was supported by a Global Research Laboratory grant from the National Research Foundation of Korea (NRF) and a EUREKA Eurostars 2 grant from EU Horizon 2020

Journal Reference:

Hyeongju Kim, Sophie Lenoir, Angela Helfricht, Taeyang Jung, Zhana K.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

A new strategy for treating Huntington's disease

09-06

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.

A new strategy to treat Huntington's disease

Related Articles

A new strategy for treating Huntington's disease